Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
WuXi Biologics Congratulates MabSpace on FDA Clearance of IND for MSB2311 2018-02-27 08:04
WuXi Biologics Congratulates Tychan for Dosing First Patient of a Zika Antibody after Record 9 Months of Development 2018-02-09 09:04
WuXi Biologics Congratulates BioAtla on FDA Clearance of IND Application for CAB-AXL-ADC 2018-01-31 07:52
WuXi Biologics and Aravive Biologics to Form Strategic Manufacturing Collaboration Following Successful IND Filing for AVB-S6-500 2018-01-30 09:00
WuXi Biologics Announces Formation of Scientific Advisory Board 2018-01-24 17:05
WuXi Biologics Appoints Dr. Chiang Syin, a Former FDA Officer as Chief Quality Officer 2018-01-15 08:10
WuXi Biologics and Phanes Sign MOU and Announce Strategic Development and Manufacturing Partnership 2017-12-14 17:20
WuXi Biologics Initiated cGMP Manufacturing in the World's Largest Biologics Manufacturing Facility Using Only Single-Use Bioreactors 2017-12-06 16:23
WuXi Biologics and Pall Corporation Establish Joint Continuous Bioprocess Laboratory 2017-11-03 10:30
WuXi Biologics Announces 2017 Interim Results 2017-08-22 14:03
WuXi Biologics and Gloria Pharmaceuticals Announce the Licensure of the Fully Human PD-1 Antibody, GLS-010, to Arcus Biosciences 2017-08-17 19:22
WuXi Biologics is Officially Listed on the Hong Kong Stock Exchange 2017-06-13 09:55
1 5 6 7 8 9